Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand

Main Article Content

Pradub Sukhum, MD

Abstract

Acute Coronary Syndrome (ACS) is the consequence of atherosclerotic plaque disruption with thrombus formation and significantly increasing different degrees of coronary artery occlusion. Using clinical features, electrocar-diogram and cardiac biomarker (troponin), ACS can be divided into

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Sukhum P. Pharmaco-invasive Therapy for STEMI; The Most Suitable STEMI Reperfusion Therapy for Transferred Patients in Thailand. BKK Med J [Internet]. 2011Feb.18 [cited 2020Dec.5];1(1):96. Available from: https://he02.tci-thaijo.org/index.php/bkkmedj/article/view/217675
Section
Clinical Practice

References

Guidelines
1. Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the Euro- pean Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Wijns W, Kolh P, Danchin N, et al.Eur Heart J 2010 Oct;31(20):2501-2555. Epub 2010 Aug 29. No abstract available.
2. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.Kushner FG, Hand M, Smith SC Jr, et al. J Am Coll Cardiol 2009 Dec 1;54 (23):2205-2241
Thrombolytic Therapy
1. Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397–401
Comparing thrombolytic and PCI therapy
1. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.Keeley EC, Boura JA, Grines CL.Lancet 2003 Jan 4;361(9351):13-20. Review.
Transfer Primary PCI
1. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction.Andersen HR, Nielsen TT, Rasmussen K, et al. DANAMI-2 Investigators. N Engl J Med 2003 Aug 21;349(8):733-742.
2. Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.Widimský P, Budesínský T, Vorác D, et al. ‘PRAGUE’ Study Group Investigators. Eur Heart J 2003 Jan;24(1):94-104
Pharmaco- invasive
1. Primary angioplasty vs. early routine post-fibrinolysis angioplasty for acute myocardial infarction with ST-segment elevation: the GRACIA-2 non-inferiority, randomized, controlled trial. Fernández-Avilés F, Alonso JJ, Peña G, et al. GRACIA-2 (Groupo de Análisis de Cardiopatía Isquémica Aguda) Investigators. Eur Heart J 2007 Apr;28(8):949-960. Epub 2007 Jan 23
2. Routine early angioplasty after fibrinolysis for acute myocardial infarction.Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, Lazzam C, Schwartz B, Casanova A, Goodman SG; TRANSFER-AMI Trial Investigators. N Engl J Med 2009 Jun 25;360(26):2705-2718
Review
1. Percutaneous Coronary Intervention After Fibrinolysis for Acute ST Elevation Myocardial Infarction. UpToDate
2. Drip-and-ship for acute ST-segment myocardial infarction: the pharmacoinvasive strategy for patients treated with fibrinolytic therapy.Goodman SG, Cantor WJ.Pol Arch Med Wewn 2009 Nov;119(11):726-730